Caburnay, Pabilta .
HRN: 28-96-51 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2026
CEFTRIAXONE 1G (VIAL)
05/07/2026
05/14/2026
IV
2g
Od
CAP MR
Checking Initial Appropriateness
05/07/2026
AZITHROMYCIN 500MG TABLET (TAB)
05/07/2026
05/11/2026
PO
50omg
Od
CAP-MR
Checking Initial Appropriateness
05/11/2026
AZITHROMYCIN 500MG TABLET (TAB)
05/11/2026
05/14/2026
PO
500mgtab
Od
Cap Mr
Checking Initial Appropriateness
05/11/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/11/2026
05/17/2026
PO
1.5gm
Q6
CAP MR
Checking Initial Appropriateness